9 tuloksia
BACKGROUND
Testosterone, delivered by subcutaneous pellet implant has been used in the United States, Europe and Australia in both men and women to treat symptoms of testosterone deficiency. Symptoms of testosterone hormone deficiency include fatigue, lack of energy, depression, memory loss,
It is known, that throughout life of a mammal or a human being, testosterone/estrone ratios do have a considerable effect on mammal or human life.
This testosterone/estrone ratio will exert a powerful and considerable reactions to the emotional well being, as well as in sexual functions, libido,
The present invention relates to pharmaceutical and veterinary formulations for the sustained release of deslorelin which is an agonist of the peptide gonadotropin releasing hormone (GnRH). Uses of the formulations include prevention of reproductive function, particularly in dogs and cats, and
The present invention relates to pharmaceutical and veterinary formulations for the sustained release of deslorelin which is an agonist of the peptide gonadotropin releasing hormone (GnRH). Uses of the formulations include prevention of reproductive function, particularly in dogs and cats, and
DESCRIPTION
TECHNICAL FIELD
The present invention relates to suicide inhibitors of aromatase which block the conversion of C.sub.19 androgens having a .DELTA..sup.4,3-ketone group to C.sub.18 estrogens. The inhibitors are particularly useful for treating estrogen-dependent carcinomas since they
This invention relates to immunogenic luteinizing hormone releasing hormone (LHRH) peptides that lead to functional suppression of LHRH levels in males or females. When male rats are immunized with these peptides, serum testosterone drops and androgen-dependent organs atrophy significantly. These
CROSS-REFERENCE TO RELATED APPLICATIONS
TABLE-US-00001 Table of Contents: Page # Line # Title 1 4 Cross reference 1 25 Background 2 23 Electron beam Radiation Therapy 3 16 Inverse Compton Scattering (ICS), Monochromatic X-Ray Imaging 4 22 Inverse Compton scattering x Ray's Electron Beam for
The present invention relates to novel 17.beta.-substituted 4-aza-5.alpha.-androstan-3-one derivatives, to a process for their preparation, and to pharmaceutical compositions containing them. These compounds are inhibitors of androgen action, by means of testosterone 5.alpha.-reductase
TECHNICAL FIELD
The present invention relates to an indole compound having a pharmacological activity and a pharmaceutically acceptable salt thereof. The present invention also relates to a medicament or a pharmaceutical composition containing the indole compound or a pharmaceutically acceptable